MAPT and Alzheimer disease: Caspase-1 has been reported to cleave tau at Asp421 [28], but caspase-1 impact in AD is more likely related to abnormal activation of the NLR family pyrin domain containing 1 (Nlrp1) inflammasome in AD neurons [55].